EUS-guided radiofrequency ablation of pancreatic neoplasm is far from being the new criterion standard

Gastrointest Endosc. 2023 Dec;98(6):1039-1040. doi: 10.1016/j.gie.2023.07.023.

Authors

Milenea Muzzolini¹, Thomas Walter², Sébastien Gaujoux³

Affiliations

¹ Department of Hepato-Pancreato-Biliary and Endocrine Surgery, La Pitié-Salpetrière Hospital, Paris, France.
² University Claude-Bernard, Lyon, France; Sorbonne University, Paris, France.
³ Department of Gastroenterology and Digestive Oncology, Edouard Herriot Hospital, Lyon, France; Sorbonne University, Paris, France.

PMID: 37977666
DOI: 10.1016/j.gie.2023.07.023

No abstract available

Publication types

Letter
Comment

MeSH terms

Endosonography
Humans
Pancreatic Neoplasms* / diagnostic imaging
Pancreatic Neoplasms* / surgery
Radiofrequency Ablation*